Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             108 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder Mischoulon, David
 2008
 18 Supplement 3 p. 639-645
7 p.
 artikel
2 Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens Jerlhag, Elisabet
 2008
 18 Supplement 3 p. 508-518
11 p.
 artikel
3 C.11.01 Can neurobiology guide the choice of treatment? Nutt, D.J.
 2008
 18 Supplement 3 p. S599-
1 p.
 artikel
4 C.20.01 Earlier diagnosis and treatment are the keys to advancing schizophrenia outcomes Correll, C.
 2008
 18 Supplement 3 p. S610-
1 p.
 artikel
5 C.05.03 Emerging new strategies for early AD diagnosis Dubois, B.
 2008
 18 Supplement 3 p. S593-
1 p.
 artikel
6 C.15.02 Managing behavioural problems in AD Feldman, H.
 2008
 18 Supplement 3 p. S604-
1 p.
 artikel
7 Cocaine self-administration produces a persistent increase in dopamine D2High receptors Briand, Lisa A.
 2008
 18 Supplement 3 p. 551-556
6 p.
 artikel
8 Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after recovery from an acute episode of moderate depression — A double-blind, randomized, placebo controlled long-term trial Kasper, S.
 2008
 18 Supplement 3 p. 803-813
11 p.
 artikel
9 C.19.02 Targeting specific symptoms in major depression Papakostas, G.
 2008
 18 Supplement 3 p. S609-
1 p.
 artikel
10 C.10.01 The lifetime trajectory of schizophrenia: from developmental pathobiology to long-term outcome and treatment Waddington, J.
 2008
 18 Supplement 3 p. S598-
1 p.
 artikel
11 C.24.03 What can we learn from large scale prospective studies – results from the sertindole cohort prospective study Moore, N.
 2008
 18 Supplement 3 p. S615-
1 p.
 artikel
12 ECNP Calendar 2008
 18 Supplement 3 p. iv-
1 p.
 artikel
13 Editorial Board 2008
 18 Supplement 3 p. IFC-
1 p.
 artikel
14 Editorial Board 2008
 18 Supplement 3 p. IFC-
1 p.
 artikel
15 Editorial Board 2008
 18 Supplement 3 p. IFC-
1 p.
 artikel
16 E.04.01 Phytotherapy in psychiatry: myths and facts Delini-Stula, A.
 2008
 18 Supplement 3 p. S200-S201
2 p.
 artikel
17 E.05.03 Psycho-education Motlova, L.
 2008
 18 Supplement 3 p. S201-S202
2 p.
 artikel
18 Experimentally induced various inflammatory models and seizure: Understanding the role of cytokine in rat Rao, R.S.
 2008
 18 Supplement 3 p. 760-767
8 p.
 artikel
19 Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats Bitencourt, Rafael M.
 2008
 18 Supplement 3 p. 849-859
11 p.
 artikel
20 Factors triggering abolishment of benzodiazepines effects in the four-plate test–retest in mice Petit-Demoulière, B.
 2008
 18 Supplement 3 p. 41-47
7 p.
 artikel
21 Keyword Index 2008
 18 Supplement 3 p. s99-s100
nvt p.
 artikel
22 P.2.a.008 Comparative study on the effectiveness of anti-depressing treatment between st. John's wort and duloxetine Istikoglou, C.
 2008
 18 Supplement 3 p. S296-S297
2 p.
 artikel
23 P.4.a.008 Comparison of anxiety-related traits between early and late onset panic disorder Shin, Y.C.
 2008
 18 Supplement 3 p. S482-
1 p.
 artikel
24 P.2.a.018 Comparison of depressive symptoms of major depressive disorder between elderly and non-elderly group in South Korea Jae, Y.M.
 2008
 18 Supplement 3 p. S302-S303
2 p.
 artikel
25 P.6.a.002 Cue-induced activation in alcohol-dependent patients pre and post treatment with and without cue-exposure based training Vollstädt-Klein, S.
 2008
 18 Supplement 3 p. S520-
1 p.
 artikel
26 P.3.a.008 Dysfunction of autonomic nervous system activity in schizophrenia and the influence of neuroleptics Kishida, I.
 2008
 18 Supplement 3 p. S389-S390
2 p.
 artikel
27 P.2.a.021 Heart rate variability and depressive symptoms in general population Park, Y.
 2008
 18 Supplement 3 p. S304-
1 p.
 artikel
28 P.2.a.035 Inflammatory response and psychopathological dimensions in major depression Camardese, G.
 2008
 18 Supplement 3 p. S312-
1 p.
 artikel
29 P.4.a.010 Integrated treatment model for panic disorder. A 3-year follow-up clinical study Vigano', C.
 2008
 18 Supplement 3 p. S483-
1 p.
 artikel
30 P.1.a.012 Interaction between brain-derived neurotrophic factor Val66Met polymorphism and negative life stressor on harm avoidance Kim, S.J.
 2008
 18 Supplement 3 p. S209-
1 p.
 artikel
31 P.8.a.026 Pharmacokinetics of (S)-zopiclone and (S)-desmethylzopiclone following dosing with zopiclone and eszopiclone Brunello, N.
 2008
 18 Supplement 3 p. S581-S582
2 p.
 artikel
32 P.3.a.005 Predictive factors for therapeutic response in first episode psychosis Baloescu, A.
 2008
 18 Supplement 3 p. S388-
1 p.
 artikel
33 P.4.a.011 P wave changes in ECG in patients with generalized anxiety disorder and the influences of sertraline Kocabasoglu, N.
 2008
 18 Supplement 3 p. S483-S484
2 p.
 artikel
34 P.8.a.023 The effect of milnacipran on tenderness in fibromyalgia: a psychophysical and fMRI analysis Gracely, R.H.
 2008
 18 Supplement 3 p. S580-
1 p.
 artikel
35 P.8.a.009 Zonisamide add-on therapy for weight loss in obese psychiatric patients Yang, J.
 2008
 18 Supplement 3 p. S571-S572
2 p.
 artikel
36 P.6.b.003 Anticraving-therapy of alcoholism in patients with comorbid arterial hypertension: abilities of paroxetine Bokhan, N.A.
 2008
 18 Supplement 3 p. S528-
1 p.
 artikel
37 P.5.b.003 Apolipoprotein E disclosure for genetic risk assessment of Alzheimer's disease: preparing for pharmacogenetics Green, R.C.
 2008
 18 Supplement 3 p. S509-S510
2 p.
 artikel
38 P.1.b.005 Auditory and visual event-related potential P300 as a “trait” and a “state” markers in patients with schizophrenia Jeon, Y.
 2008
 18 Supplement 3 p. S219-S220
2 p.
 artikel
39 P.8.b.002 Early maternal experience, maternal sensitivity, infant emotion regulation and HPA function Gonzalez, A.
 2008
 18 Supplement 3 p. S587-S588
2 p.
 artikel
40 P.2.b.016 Effects of antidepressant treatment on the intensity dependence of auditory evoked potential components Linka, T.
 2008
 18 Supplement 3 p. S321-S322
2 p.
 artikel
41 P.3.b.002 Isolation rearing-induced cognitive deficits involves opposing NMDA/D1 receptor changes in rat frontal cortex Harvey, B.
 2008
 18 Supplement 3 p. S398-
1 p.
 artikel
42 P.4.b.010 Reduction of fearful state in rats exposed to predator odor by inhibition of nitric oxide transmission in the midbrain Souza, R.R.
 2008
 18 Supplement 3 p. S492-
1 p.
 artikel
43 P.2.b.013 The antidepressant effect of the hypericum extracts Ze-117 and LI-160 depends on total liver's cytochrome P450 activity Bellido, I.
 2008
 18 Supplement 3 p. S320-
1 p.
 artikel
44 P.5.b.006 The influence of apolipoprotein E epsilon4 allele on cognitive function in questionable dementia Moon, S.
 2008
 18 Supplement 3 p. S511-S512
2 p.
 artikel
45 P.3.c.066 Adjunctive long-acting risperidone delays mood episode relapse in patients with frequently relapsing bipolar disorder Alphs, L.
 2008
 18 Supplement 3 p. S441-S442
2 p.
 artikel
46 P.1.36 Caffeine exacerbates MDMA “Ecstasy”-induced hyperthermia: a role for dopamine D1 receptors Vanattou-Saifoudine, N.
 2008
 18 Supplement 3 p. s30-s31
nvt p.
 artikel
47 P.2.c.026 A new strategy of continuation pharmacotherapy in the prevention of relapse following ECT: a controlled trial Yildiz, A.
 2008
 18 Supplement 3 p. S339-S340
2 p.
 artikel
48 P.2.c.023 Are moclobemide trough concentrations an adequate predictor of the systemic drug exposure Ignjatovic, A. Rakic
 2008
 18 Supplement 3 p. S337-S338
2 p.
 artikel
49 P.6.c.004 Association between the val158met polymorphism in the catechol-o-methyltransferase (comt) gene and cocaine dependence Lohoff, F.W.
 2008
 18 Supplement 3 p. S533-S534
2 p.
 artikel
50 P.3.c.049 Case series on the use of aripiprazole for tic disorder Semerci, B.
 2008
 18 Supplement 3 p. S432-
1 p.
 artikel
51 P.1.c.026 Effect of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation Aubry, J.M.
 2008
 18 Supplement 3 p. S234-S235
2 p.
 artikel
52 P.3.c.004 Effects of drd3 and dat gene polymorphisms on schizophrenia and response to olanzapine Sengul, C.
 2008
 18 Supplement 3 p. S406-S407
2 p.
 artikel
53 P.6.c.007 Emotional intelligence and meta mood in a sample of egyptian substance use disorder patients ElGhonemy, S.
 2008
 18 Supplement 3 p. S535-S536
2 p.
 artikel
54 P.3.c.017 Impact of psychoeducation and drug side effects on inpatient psychiatric satisfaction with schizophrenic patients Kim, C.K.
 2008
 18 Supplement 3 p. S414-
1 p.
 artikel
55 P.1.c.040 MDMA induces oxytocin release in humans Dumont, G.
 2008
 18 Supplement 3 p. S242-
1 p.
 artikel
56 P.1.c.016 Metabolic profile of eslicarbazepine acetate in mice and the role of liver in the systemic drug exposure Alves, G.
 2008
 18 Supplement 3 p. S229-
1 p.
 artikel
57 P.3.c.032 Monotherapy with amisulpride in an acute hospitalization unit (clinical uses under indication and off-label) Sala, M. Planella
 2008
 18 Supplement 3 p. S422-
1 p.
 artikel
58 P.3.c.007 Olanzapine ameliorates psychotic excitement in schizophrenics influencing catecholamine metabolites, cytokines, and BDNF Nakamura, J.
 2008
 18 Supplement 3 p. S408-
1 p.
 artikel
59 P.2.c.009 Preliminary analysis of trazodone and pregabalin association in the treatment of fibromyalgia Vilchez, J.
 2008
 18 Supplement 3 p. S329-S330
2 p.
 artikel
60 P.3.c.063 Prolactin level as an indicator to clinical psychopathological severity in aripiprazole treated schizophrenia Lan, T.
 2008
 18 Supplement 3 p. S440-
1 p.
 artikel
61 P.1.c.030 Proteomic analysis or rat brain after treatment with risperidone Kim, B.C.
 2008
 18 Supplement 3 p. S237-
1 p.
 artikel
62 P.7.c.002 Quality of life and parent satisfaction with the methylphenidate transdermal system López, F.A.
 2008
 18 Supplement 3 p. S562-
1 p.
 artikel
63 P.1.c.013 Some molecular aspects of haloperidol's neurotoxicity Zhuravliova, E.
 2008
 18 Supplement 3 p. S227-
1 p.
 artikel
64 P.3.d.017 Agonist-dependent internalization of 5-HT6 receptors visualized by immunofluorescence assay: blockade by antipsychotics Dupuis, D.S.
 2008
 18 Supplement 3 p. S458-
1 p.
 artikel
65 P.3.d.020 Atypical neuroleptics may modify cortical oscillatory activity in schizophrenia Mayner, G.
 2008
 18 Supplement 3 p. S459-S460
2 p.
 artikel
66 P.1.d.003 Effects of early maternal separation during the development on the behavioral change in the forced swimming test in rats Chung, Y.
 2008
 18 Supplement 3 p. S250-
1 p.
 artikel
67 P.1.d.006 Effects of LY379268, a selective agonist of mGlu2/3 receptors, on isolation-induced aggression in male mice Navarro, J.F.
 2008
 18 Supplement 3 p. S252-
1 p.
 artikel
68 P.6.d.008 Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward Benturquia, N.
 2008
 18 Supplement 3 p. S544-
1 p.
 artikel
69 P.2.d.004 Modulation of locus coeruleus noradrenergic neurons by fluoxetine Miguelez, C.
 2008
 18 Supplement 3 p. S347-
1 p.
 artikel
70 P.3.d.003 Study investigating R231857 effects on scopolamine-induced CNS impairment in healthy men Liem-Moolenaar, M.
 2008
 18 Supplement 3 p. S449-S450
2 p.
 artikel
71 P.1.e.002 A case of transient global amnesia with high signal intensities at the both hippocampi on diffusion-weighted MRI Kim, H.C.
 2008
 18 Supplement 3 p. S260-
1 p.
 artikel
72 P.1.e.016 Anatomical abnormalities of the anterior cingulate cortex before the onset of psychosis Fornito, A.
 2008
 18 Supplement 3 p. S268-S269
2 p.
 artikel
73 P.2.e.020 Effects of valproate and atypical antipsychotics on bone mineral density in female patients with bipolar disorder Yang, J.
 2008
 18 Supplement 3 p. S370-
1 p.
 artikel
74 P.2.e.006 Occupational outcome of lithium-treated bipolar patients in clinical remission Portella, M.J.
 2008
 18 Supplement 3 p. S362-
1 p.
 artikel
75 P.1.e.019 PET-measured occupancy of the norepinephrene transporter by extended release quetiapine fumarate (quetiapine XR) in brains of healthy subjects Nyberg, S.
 2008
 18 Supplement 3 p. S270-
1 p.
 artikel
76 P.2.e.023 Placebo-controlled study with acute and continuation phase of quetiapine in adults with bipolar depression (EMBOLDEN II) Young, A.
 2008
 18 Supplement 3 p. S371-S372
2 p.
 artikel
77 P.3.e.021 Psychopharmacological treatment in catatonic schizophrenia Ciobanu, A.
 2008
 18 Supplement 3 p. S473-
1 p.
 artikel
78 P.3.e.011 Psychotic disorders and risk for later cancer: a cohort study Weiser, M.
 2008
 18 Supplement 3 p. S467-S468
2 p.
 artikel
79 P.6.f.001 Early smoking onset and other substance use: the risk and speed of transition to regular nicotine use and dependence Behrendt, S.
 2008
 18 Supplement 3 p. S552-
1 p.
 artikel
80 P.4.f.003 Effect of stress on brain activation patterns in women with postpartum obsessive-compulsive and depressive disorders Lord, C.
 2008
 18 Supplement 3 p. S501-S502
2 p.
 artikel
81 P.6.f.004 Effects of opioid antagonists on the rats behavior in the open field Basishvili, T.
 2008
 18 Supplement 3 p. S553-S554
2 p.
 artikel
82 P.2.g.012 Estimation of therapeutic efficacy of magnetic fields in patients with drug-resistant depression Sobis, J.
 2008
 18 Supplement 3 p. S379-S380
2 p.
 artikel
83 P.1.g.010 Oxidative stress damage of hippocampus induced memory impairment in rats Padurariu, M.
 2008
 18 Supplement 3 p. S278-S279
2 p.
 artikel
84 P.1.g.016 Relative contribution of the alpha2-, 3- and 5-containing GABAA receptors to benzodiazepine effects in the water maze Joksimovic, S.
 2008
 18 Supplement 3 p. S282-
1 p.
 artikel
85 Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the glycine transporter-1 inhibitor NFPS and d-serine Hashimoto, Kenji
 2008
 18 Supplement 3 p. 414-421
8 p.
 artikel
86 P.1.35 Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A Tamburella, A.
 2008
 18 Supplement 3 p. s29-s30
nvt p.
 artikel
87 Phosphodiesterase 10A inhibition is associated with locomotor and cognitive deficits and increased anxiety in mice Hebb, Andrea L.O.
 2008
 18 Supplement 3 p. 339-363
25 p.
 artikel
88 P.1.i.002 Ca2+ buffering by mitochondria – key mechanism for modulation of store-operated Ca2+ entry induced by neurotransmitters Kopach, O.
 2008
 18 Supplement 3 p. S288-S289
2 p.
 artikel
89 P.1.05 Involvement of DARPP-32, FosB, and dynorphin in voluntary wheel running Borgkvist, A.
 2008
 18 Supplement 3 p. s5-s6
nvt p.
 artikel
90 PL.02.01 Has serotonin a role in the development of the social brain? Lesch, K.P.
 2008
 18 Supplement 3 p. S153-
1 p.
 artikel
91 P.4.03 Rational design of a drug for Alzheimer's disease with cholinesterase inhibitory and neuroprotective activity Groner, E.
 2008
 18 Supplement 3 p. s87-
1 p.
 artikel
92 P.2.27 Role of neurosteroids in the modulation of neuropeptide Y Y1 receptor neurotransmission during ethanol and ghb withdrawal Mele, P.
 2008
 18 Supplement 3 p. s58-s59
nvt p.
 artikel
93 P.3.14 Specific antipsychotic medications—a treatment for aggressive behaviour in schizophrenia? Patel, K.
 2008
 18 Supplement 3 p. s73-s74
nvt p.
 artikel
94 P.1.22 Synaptoproteomic analysis of a rat model of depression with gene-environment interaction Mallei, A.
 2008
 18 Supplement 3 p. s19-s20
nvt p.
 artikel
95 P.2.13 Translational research into sexual disorders: pharmacology and behavior Chan, J.
 2008
 18 Supplement 3 p. s47-s48
nvt p.
 artikel
96 P.2.30 Triple dissociation of serotonergic in.uence on motivational behaviour under positive, negative and neutral mood Robinson, O.J.
 2008
 18 Supplement 3 p. s60-s61
nvt p.
 artikel
97 Relationship between antidepressants and IGF-1 system in the brain: Possible role in cognition Grunbaum-Novak, Nurit
 2008
 18 Supplement 3 p. 431-438
8 p.
 artikel
98 S.26.02 Alcoholism-associated molecular adaptations in endogenous opioids in brain neurocognitive circuits: human and animal correlates Bakalkin, G.
 2008
 18 Supplement 3 p. S194-
1 p.
 artikel
99 S.23.01 Antidepressants and emotional processing Harmer, C.
 2008
 18 Supplement 3 p. S189-
1 p.
 artikel
100 S.09.05 Antihypertensive treatment on cognitive functions in Alzheimer's disease Skoog, I.
 2008
 18 Supplement 3 p. S173-
1 p.
 artikel
101 S.20.04 Lithium responsive behavioural models: a tool for understanding atypical antipsychotic action in bipolar depression and mania Gould, T.
 2008
 18 Supplement 3 p. S184-S185
2 p.
 artikel
102 S.03.04 Metabolic state regulation of hypocretin/orexin neurones: mechanisms and implications for feeding behaviour Burdakov, D.
 2008
 18 Supplement 3 p. S159-
1 p.
 artikel
103 S.16.02 Neural stem cells and differentiation Conti, L.
 2008
 18 Supplement 3 p. S178-
1 p.
 artikel
104 S.09.01 New concept and new criteria of Alzheimer's disease Dubois, B.
 2008
 18 Supplement 3 p. S172-
1 p.
 artikel
105 S.06.03 Phenotyping OCD: new insights from animal behaviour Eilam, D.
 2008
 18 Supplement 3 p. S166-
1 p.
 artikel
106 S.2.01 Psychopharmacological models focusing on stimulus bound behaviour Markou, A.
 2008
 18 Supplement 3 p. s35-s36
nvt p.
 artikel
107 S.20.01 Studies on lithium by the use of GSK-3b knockout mice Belmaker, R.
 2008
 18 Supplement 3 p. S183-S184
2 p.
 artikel
108 Strategies of treatment with olanzapine in schizophrenic patients during stable phase: Results of a pilot study Rouillon, Frédéric
 2008
 18 Supplement 3 p. 646-652
7 p.
 artikel
                             108 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland